Brief: Hisamitsu Pharmaceutical's Management Is Considering A Takeover Bid To Privatize The Japanese Maker Of Salonpas - Bloomberg News
Jan 5 (Reuters) - HISAMITSU PHARMACEUTICAL'S MANAGEMENT IS CONSIDERING A TAKEOVER BID TO PRIVATIZE THE JAPANESE MAKER OF SALONPAS - BLOOMBERG NEWS A DEAL TO TAKE HISAMITSU PRIVATE COULD BE WORTH AROUND ¥450 BILLION ($2.9 BILLION) - BLOOMBERG NEWS Source text: https://tinyurl.com/uyf2j5ut Further company coverage: 4530.T ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Hisamitsu Pharmaceutical Co
See all newsTable: Hisamitsu -2025/26 group results
Table: Hisamitsu -2025/26 parent results
Brief: Hisamitsu Pharmaceutical Co Inc - To Retire Treasury Shares Worth 6.34% Of Outstanding Stock On May 12
Brief: Hisamitsu Pharmaceutical Co Inc - Tender Offer Of Company By Taiyo Kosan Successfully Completed
Japan's Hisamitsu Pharmaceutical plans $2.55 billion MBO